BlinkLab is trading 12.12% up now at A$0.74, with the move most consistent with supportive healthcare-sector rotation.
- The stock rose from the September 15 close of A$0.66.
- No September 16, 2026 company-specific announcement was identified; the latest material filing was the September 8 appointment of former Apple Health clinical lead Dr Raphael Bernier.
- XLV is up 1.28%, though BlinkLab’s gain is substantially larger.